Literature DB >> 26722462

miR-34c-3p inhibits cell proliferation, migration and invasion of hepatocellular carcinoma by targeting MARCKS.

Jianjun Song1, Qi Wang1, Yongyun Luo1, Peng Yuan1, Chaofeng Tang1, Yongfeng Hui1, Zuozheng Wang1.   

Abstract

Recent studies have shown that microRNA-34c-3p (miR-34c-3p) is down-regulated in various types of cancers and involved in tumor growth, invasion and metastasis. However, the roles of miR-34c-3p in hepatocellular carcinoma (HCC) are poorly understood. In this study, the expression profile of miR-34c-3pin HCC tissues and cell lines were examined by quantitative real-time polymerase chain reaction (qRT-PCR). The correlations of miR-34c-3p expression and clinicopathological characteristics were analyzed. The biological role of MiR-34c-3pin cell proliferation, migration and invasion was examined. In addition, the targets of miR-34c-3p were identified. The results showed that miR-34c-3p expression was significantly down-regulated in HCC tissues and cell lines; low expression level of miR-34c-3p was correlated with vascular invasion and advanced TNM stage. In vitro functional assays showed that overexpression of miR-34c-3pin HepG2 and Huh7 cells significantly reduced cell proliferation, migration and invasion. Furthermore, target analysis and luciferase assay identified myristoylated alanine-rich protein kinase c substrate (MARCKS) as a specific target of miR-34c-3p. Knockdown of MARCKS in HepG2 cells reduced cell migration and invasion, but not cell proliferation. Taken together, our findings implicate the potential application of miR-34c-3p as a tumor suppressor in cancer therapy.

Entities:  

Keywords:  MARCKS; MiR-34c-3p; hepatocellular carcinoma; tumor suppressor

Mesh:

Substances:

Year:  2015        PMID: 26722462      PMCID: PMC4680407     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  22 in total

Review 1.  MicroRNA biogenesis pathways in cancer.

Authors:  Shuibin Lin; Richard I Gregory
Journal:  Nat Rev Cancer       Date:  2015-06       Impact factor: 60.716

2.  Frequent downregulation of miR-34 family in human ovarian cancers.

Authors:  David C Corney; Chang-Il Hwang; Andres Matoso; Markus Vogt; Andrea Flesken-Nikitin; Andrew K Godwin; Aparna A Kamat; Anil K Sood; Lora H Ellenson; Heiko Hermeking; Alexander Yu Nikitin
Journal:  Clin Cancer Res       Date:  2010-02-09       Impact factor: 12.531

3.  miR-128-3p suppresses hepatocellular carcinoma proliferation by regulating PIK3R1 and is correlated with the prognosis of HCC patients.

Authors:  Chao-Yuan Huang; Xin-Ping Huang; Ji-Ye Zhu; Zhi-Gang Chen; Xian-Jian Li; Xue-Hui Zhang; Shan Huang; Jian-Bo He; Fang Lian; Yin-Nong Zhao; Guo-Bin Wu
Journal:  Oncol Rep       Date:  2015-04-28       Impact factor: 3.906

4.  Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver.

Authors:  Tsutomu Masaki; Masaaki Tokuda; Shuhei Yoshida; Seiji Nakai; Asahiro Morishita; Naohito Uchida; Toshiharu Funaki; Yuko Kita; Fumi Funakoshi; Takako Nonomura; Takashi Himoto; Akihiro Deguchi; Yasuhiko Kimura; Kunihiko Izuishi; Hisao Wakabayashi; Hisashi Usuki; Hitoshi Yoshiji; Seishiro Watanabe; Kazutaka Kurokohchi; Shigeki Kuriyama
Journal:  Int J Oncol       Date:  2005-03       Impact factor: 5.650

5.  Membrane association of the myristoylated alanine-rich C kinase substrate (MARCKS) protein. Mutational analysis provides evidence for complex interactions.

Authors:  S L Swierczynski; P J Blackshear
Journal:  J Biol Chem       Date:  1995-06-02       Impact factor: 5.157

6.  MicroRNAs involved in neoplastic transformation of liver cancer stem cells.

Authors:  Ren Li; Niansong Qian; Kaishan Tao; Nan You; Xinchuan Wang; Kefeng Dou
Journal:  J Exp Clin Cancer Res       Date:  2010-12-23

7.  Differential effects of miR-34c-3p and miR-34c-5p on the proliferation, apoptosis and invasion of glioma cells.

Authors:  Zhendong Wu; Yupeng Wu; Ye Tian; Xiaofeng Sun; Jixiang Liu; Hongbo Ren; Chaohui Liang; Ligang Song; Hongchao Hu; Liqun Wang; Baohua Jiao
Journal:  Oncol Lett       Date:  2013-09-12       Impact factor: 2.967

8.  Protein kinase Cepsilon is important for migration of neuroblastoma cells.

Authors:  Helena Stensman; Christer Larsson
Journal:  BMC Cancer       Date:  2008-12-11       Impact factor: 4.430

9.  MiR-141 suppresses the migration and invasion of HCC cells by targeting Tiam1.

Authors:  Ying Liu; Yi Ding; Jing Huang; Shuang Wang; Wen Ni; Jian Guan; Qisheng Li; Yuqin Zhang; Yanqing Ding; Bin Chen; Longhua Chen
Journal:  PLoS One       Date:  2014-02-13       Impact factor: 3.240

Review 10.  miR-34: from bench to bedside.

Authors:  Massimiliano Agostini; Richard A Knight
Journal:  Oncotarget       Date:  2014-02-28
View more
  13 in total

1.  MicroRNA-34c-3p promotes cell proliferation and invasion in hepatocellular carcinoma by regulation of NCKAP1 expression.

Authors:  Cheng-Zuo Xiao; Wei Wei; Zhi-Xing Guo; Mei-Yin Zhang; Yong-Fa Zhang; Jia-Hong Wang; Ming Shi; Hui-Yun Wang; Rong-Ping Guo
Journal:  J Cancer Res Clin Oncol       Date:  2016-10-04       Impact factor: 4.553

2.  miRNA-34c inhibits myoblasts proliferation by targeting YY1.

Authors:  Meng Wang; Chuncheng Liu; Yang Su; Kuo Zhang; Yuying Zhang; Min Chen; Mengxu Ge; Lijie Gu; Tianyu Lu; Ning Li; Zhengquan Yu; Qingyong Meng
Journal:  Cell Cycle       Date:  2017-01-26       Impact factor: 4.534

Review 3.  MARCKS and Lung Disease.

Authors:  Mary K Sheats; Qi Yin; Shijing Fang; Joungjoa Park; Anne L Crews; Indu Parikh; Brian Dickson; Kenneth B Adler
Journal:  Am J Respir Cell Mol Biol       Date:  2019-01       Impact factor: 6.914

Review 4.  Pathophysiological roles of myristoylated alanine-rich C-kinase substrate (MARCKS) in hematological malignancies.

Authors:  Deepak Narayanan Iyer; Omar Faruq; Lun Zhang; Nasrin Rastgoo; Aijun Liu; Hong Chang
Journal:  Biomark Res       Date:  2021-05-06

5.  Discovery and Optimization of N-Substituted 2-(4-pyridinyl)thiazole carboxamides against Tumor Growth through Regulating Angiogenesis Signaling Pathways.

Authors:  Wenbo Zhou; Wenshu Tang; Zhenliang Sun; Yunqi Li; Yanmin Dong; Haixiang Pei; Yangrui Peng; Jinhua Wang; Ting Shao; Zhenran Jiang; Zhengfang Yi; Yihua Chen
Journal:  Sci Rep       Date:  2016-09-16       Impact factor: 4.379

6.  Spatial Tissue Proteomics Quantifies Inter- and Intratumor Heterogeneity in Hepatocellular Carcinoma (HCC).

Authors:  Katarzyna Buczak; Alessandro Ori; Joanna M Kirkpatrick; Kerstin Holzer; Daniel Dauch; Stephanie Roessler; Volker Endris; Felix Lasitschka; Luca Parca; Alexander Schmidt; Lars Zender; Peter Schirmacher; Jeroen Krijgsveld; Stephan Singer; Martin Beck
Journal:  Mol Cell Proteomics       Date:  2018-01-23       Impact factor: 5.911

7.  Significantly different expression levels of microRNAs associated with vascular invasion in hepatocellular carcinoma and their prognostic significance after surgical resection.

Authors:  Sung Kyu Song; Woon Yong Jung; Seung-Keun Park; Chul-Woon Chung; Yongkeun Park
Journal:  PLoS One       Date:  2019-09-12       Impact factor: 3.240

Review 8.  From Liver Cirrhosis to Cancer: The Role of Micro-RNAs in Hepatocarcinogenesis.

Authors:  Raphael Mohr; Burcin Özdirik; Joeri Lambrecht; Münevver Demir; Johannes Eschrich; Lukas Geisler; Teresa Hellberg; Sven H Loosen; Tom Luedde; Frank Tacke; Linda Hammerich; Christoph Roderburg
Journal:  Int J Mol Sci       Date:  2021-02-02       Impact factor: 5.923

9.  MARCKSL1 promotes the proliferation, migration and invasion of lung adenocarcinoma cells.

Authors:  Wenjun Liang; Ruichen Gao; Mingxia Yang; Xiaohua Wang; Kewei Cheng; Xuejun Shi; Chen He; Yemei Li; Yuying Wu; Lei Shi; Jingtao Chen; Xiaowei Yu
Journal:  Oncol Lett       Date:  2020-01-17       Impact factor: 2.967

10.  miR-34c Targets MET to Improve the Anti-Tumor Effect of Cisplatin on Ovarian Cancer.

Authors:  Shiying Yang; Zhen Li; Rui Luo
Journal:  Onco Targets Ther       Date:  2020-04-05       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.